Literature DB >> 23000230

Regulatory T-cell therapy for Crohn's disease: in vivo veritas.

Silvio Danese1, Gionata Fiorino2, Sergio Rutella3.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23000230     DOI： 10.1053/j.gastro.2012.09.019

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

1.  Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.

Authors:  Oriol Juanola; Alba Moratalla; Ana Gutiérrez; Laura Sempere; Pedro Zapater; Paula Giménez; Isabel Almenta; Gloria Peiró; José M González-Navajas; José F Such; Rubén Francés
Journal:  J Gastroenterol       Date:  2014-12-11       Impact factor: 7.527

2.  FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents.

Authors:  Luisa Guidi; Carla Felice; Annabella Procoli; Giuseppina Bonanno; Enrica Martinelli; Manuela Marzo; Giammarco Mocci; Daniela Pugliese; Gianluca Andrisani; Silvio Danese; Italo De Vitis; Alfredo Papa; Alessandro Armuzzi; Sergio Rutella
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.